OCUL

NASDAQStock

Ocular Therapeutix, Inc.

$8.88-0.62 (-6.53%)

52-Week Range

$6.02

$16.11

Key Stats

Market Cap

1.9B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Volume

4.5M

Avg Volume

7.5M

Performance

-3.17%

-37.40%

-29.27%

YTD

-24.96%

+12.56%

+73.92%

-55.61%

Price Chart

ETF Exposure

OCUL is held by 59 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	88	$868	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	101	$998	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	120	$1K	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	100	$984	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	66	$650	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	50	$491	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	22	$218	$9.5M	0.12%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	16	$154	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	52	$510	$81.5M	0.10%

PreviousPage 2 of 2

About OCUL ETF Exposure

Ocular Therapeutix, Inc. (OCUL) is held by 59 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.9B, OCUL is a widely held institutional stock. The stock currently trades at $8.88. Investors can gain exposure to OCUL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold OCUL, sorted by portfolio weight.